KunTuo

KunTuo is a China-focused full-service contract research organization (CRO) that provides clinical development and regulatory services for pharmaceutical, medical device, and in vitro diagnostic companies. The company was established in China in 2011 and operates as a wholly owned subsidiary of IQVIA, serving sponsors conducting clinical trials in China from IND through NDA. Its offerings include regulatory affairs, clinical monitoring, pharmacovigilance and safety management, medical affairs, data management and biostatistics, site management, project management, and medical translation. KunTuo appears to be a service provider rather than a therapeutics developer, so it does not have a disclosed proprietary drug pipeline in the conventional biotech sense. The company has also positioned itself as a partner for advanced therapy developers through collaborations around gene and cell therapy clinical development and manufacturing ecosystems in China.